Central Trust CO Perkinelmer Inc Transaction History

Central Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	N/A	-50 Reduced 25.0%	150 $18,000
Q1 2024 Apr 24, 2024	SELL	N/A	-50 Reduced 20.0%	200 $24,000
Q2 2022 Aug 09, 2022	SELL	$134.91 - $172.49 $6,205 - $7,934	-46 Reduced 15.54%	250 $36,000
Q3 2021 Oct 19, 2021	BUY	$151.98 - $190.5 $151 - $190	1 Added 0.34%	296 $51,000
Q2 2021 Jul 23, 2021	SELL	$127.81 - $155.84 $470,340 - $573,491	-3,680 Reduced 92.58%	295 $45,000
Q1 2021 Apr 23, 2021	BUY	$120.35 - $160.53 $433,260 - $577,908	3,600 Added 960.0%	3,975 $509,000
Q3 2020 Oct 22, 2020	BUY	$97.09 - $125.51 $2,427 - $3,137	25 Added 7.14%	375 $47,000
Q1 2020 Apr 17, 2020	SELL	$66.71 - $101.73 $3,335 - $5,086	-50 Reduced 12.5%	350 $26,000
Q3 2017 Oct 17, 2017	BUY	$62.95 - $69.48 $25,180 - $27,792	400	400 $0

574

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.